Dose-finding study of valspodar (PSC 833) with daunorubicin and cytarabine to reverse multidrug resistance in elderly patients with previously untreated acute myeloid leukemia.

P. Sonneveld; A. Burnett; P. Vossebeld; M. Ben-Am; G. Rosenkranz; C. Pfister; G. Verhoef; A.W. Dekker; G.J. Ossenkoppele; C. Ferrant; L. Yin; A. Gratwohl; T. Kovacsovics; E. Vellenga; R. Capdeville; B. Lowenberg

Dose-finding study of valspodar (PSC 833) with daunorubicin and cytarabine to reverse multidrug resistance in elderly patients with previously untreated acute myeloid leukemia.

Translated title of the contribution: Dose-finding study of valspodar (PSC 833) with daunorubicin and cytarabine to reverse multidrug resistance in elderly patients with previously untreated acute myeloid leukemia.

P. Sonneveld
, A. Burnett
, P. Vossebeld
, M. Ben-Am
, G. Rosenkranz
, C. Pfister
, G. Verhoef
, A.W. Dekker
, G.J. Ossenkoppele
, C. Ferrant
, L. Yin
, A. Gratwohl
, T. Kovacsovics
, E. Vellenga
, R. Capdeville
, B. Lowenberg

Hematology/Van Creveldclinic

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Dose-finding study of valspodar (PSC 833) with daunorubicin and cytarabine to reverse multidrug resistance in elderly patients with previously untreated acute myeloid leukemia.
Original language	Undefined/Unknown
Pages (from-to)	411-421
Number of pages	11
Journal	The Hematology Journal
Volume	1
Publication status	Published - 2000

Cite this

Sonneveld, P., Burnett, A., Vossebeld, P., Ben-Am, M., Rosenkranz, G., Pfister, C., Verhoef, G., Dekker, A. W., Ossenkoppele, G. J., Ferrant, C., Yin, L., Gratwohl, A., Kovacsovics, T., Vellenga, E., Capdeville, R., & Lowenberg, B. (2000). Dose-finding study of valspodar (PSC 833) with daunorubicin and cytarabine to reverse multidrug resistance in elderly patients with previously untreated acute myeloid leukemia. The Hematology Journal, 1, 411-421.

@article{943d2935a75240f0a5d2899c5f8815d4,

title = "Dose-finding study of valspodar (PSC 833) with daunorubicin and cytarabine to reverse multidrug resistance in elderly patients with previously untreated acute myeloid leukemia.",

author = "P. Sonneveld and A. Burnett and P. Vossebeld and M. Ben-Am and G. Rosenkranz and C. Pfister and G. Verhoef and A.W. Dekker and G.J. Ossenkoppele and C. Ferrant and L. Yin and A. Gratwohl and T. Kovacsovics and E. Vellenga and R. Capdeville and B. Lowenberg",

year = "2000",

language = "Undefined/Unknown",

volume = "1",

pages = "411--421",

journal = "The Hematology Journal",

issn = "1466-4860",

publisher = "Nature Publishing Group",

}

Sonneveld, P, Burnett, A, Vossebeld, P, Ben-Am, M, Rosenkranz, G, Pfister, C, Verhoef, G, Dekker, AW, Ossenkoppele, GJ, Ferrant, C, Yin, L, Gratwohl, A, Kovacsovics, T, Vellenga, E, Capdeville, R & Lowenberg, B 2000, 'Dose-finding study of valspodar (PSC 833) with daunorubicin and cytarabine to reverse multidrug resistance in elderly patients with previously untreated acute myeloid leukemia.', The Hematology Journal, vol. 1, pp. 411-421.

TY - JOUR

T1 - Dose-finding study of valspodar (PSC 833) with daunorubicin and cytarabine to reverse multidrug resistance in elderly patients with previously untreated acute myeloid leukemia.

AU - Sonneveld, P.

AU - Burnett, A.

AU - Vossebeld, P.

AU - Ben-Am, M.

AU - Rosenkranz, G.

AU - Pfister, C.

AU - Verhoef, G.

AU - Dekker, A.W.

AU - Ossenkoppele, G.J.

AU - Ferrant, C.

AU - Yin, L.

AU - Gratwohl, A.

AU - Kovacsovics, T.

AU - Vellenga, E.

AU - Capdeville, R.

AU - Lowenberg, B.

PY - 2000

Y1 - 2000

M3 - Article

SN - 1466-4860

VL - 1

SP - 411

EP - 421

JO - The Hematology Journal

JF - The Hematology Journal

ER -